Arch Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.232; its P/E ratio is -0.36; Arch Therapeutics is scheduled to report earnings on May 14, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 45.87K	$ 13.29K	$ 16.65K	$ 6.26K	$ 1.57K
Gross Profit	$ 45.87K	$ 13.29K	$ 35.37K	$ -11.37K	$ 1.44K
EBIT	$ -1.47M	$ -1.01M	$ 2.62M	$ -1.28M	$ -1.44M
EBITDA	$ -1.47M	$ -1.01M	$ 2.62M	$ -1.28M	$ -1.44M
Net Income Common Stockholders	$ -2.68M	$ -1.82M	$ 1.98M	$ -1.80M	$ -1.89M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 205.85K	$ 86.54K	$ 29.50K	$ 10.62K	$ 746.94K
Total Assets	$ 1.82M	$ 1.56M	$ 1.59M	$ 1.72M	$ 2.60M
Total Debt	$ 0.00	$ 690.01K	$ 0.00	$ 0.00	$ 3.36M
Net Debt	$ -205.85K	$ 603.47K	$ -29.50K	$ -10.62K	$ 2.62M
Total Liabilities	$ 4.12M	$ 9.58M	$ 7.98M	$ 7.60M	$ 6.80M
Stockholders Equity	$ -9.58M	$ -8.02M	$ -6.39M	$ -5.89M	$ -4.19M
Cash Flow	-
Free Cash Flow	$ -862.61K	$ -4.43M	$ -599.87K	$ -650.07K	$ -1.67M
Operating Cash Flow	$ -862.61K	$ -4.43M	$ -599.87K	$ -650.07K	$ -1.67M
Investing Cash Flow	-	-	-	-	$ 0.00
Financing Cash Flow	$ 845.74K	$ -532.49K	$ 618.74K	$ -86.26K	$ 2.36M

Currency in USD

Arch Therapeutics Earnings and Revenue History

Income Statement >

Arch Therapeutics Debt to Assets

Balance Sheet >

Arch Therapeutics Cash Flow

Cash Flow >

Arch Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing